insights_auto
ANW の上昇理由: 51.28%?
さらに詳しくchevron_right
ANW:FRA
Immuron Ltd
€0.030
arrow_upward
+51.28%(+0.010) 1 日
10月12日, 8:05:52 GMT+2 · EUR
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoANW の上位の分析情報を生成しています...
始値
€0.03
高値
€0.03
安値
€0.03
時価総額
1220.37万
平均出来高
627.00
取引量
8300.00
52 週高値
€0.04
52 週安値
€0.01
従業員数
8
始値
€0.03
高値
€0.03
安値
€0.03
時価総額
1220.37万
平均出来高
627.00
取引量
8300.00
52 週高値
€0.04
52 週安値
€0.01
従業員数
8
ニュース記事
情報源: ウェブソース、ニュース パートナー
https://www.dars.gov.et/
·
6 日前
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - MA Cross Alert
プロフィール
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Immuron Ltd について